PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Aarkstore Herpes Zoster (Shingles) Pipeline Review .pdf


Original filename: Aarkstore - Herpes Zoster (Shingles) - Pipeline Review.pdf
Title: Texto
Author: Mariajose

This PDF 1.5 document has been generated by Microsoft® Office PowerPoint® 2007, and has been sent on pdf-archive.com on 05/05/2015 at 09:41, from IP address 111.119.x.x. The current document download page has been viewed 416 times.
File size: 326 KB (11 pages).
Privacy: public file




Download original PDF file









Document preview


Aarkstore - Herpes Zoster (Shingles)
- Pipeline Review, H2 2014

www.aarkstore.com

Summary
“Herpes Zoster (Shingles) - Pipeline Review, H2 2014”, provides an overview of the
Herpes Zoster (Shingles)s therapeutic pipeline.
This Market Research Report provides comprehensive information on the therapeutic
development for Herpes Zoster (Shingles), complete with comparative analysis at various
stages, therapeutics assessment by drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type, along with latest updates, and featured news and
press releases. It also reviews key players involved in the therapeutic development for Herpes
Zoster (Shingles) and special features on late-stage and discontinued projects.

www.aarkstore.com
www.aarkstore.com

Scope
- The report provides a snapshot of the global therapeutic landscape of Herpes Zoster (Shingles)
- The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental
activities
- The report reviews key players involved in the therapeutics development for Herpes Zoster
(Shingles) and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Herpes Zoster (Shingles) products under development by companies and
universities/research institutes based on information derived from company and industryspecific sources
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Herpes Zoster (Shingles) pipeline on the basis of target, MoA, route of
administration and molecule type
- Latest news and deals relating related to pipeline products

www.aarkstore.com

Reasons to buy
- Provides strategically significant competitor information, analysis, and insights to formulate
effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective
counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for
Herpes Zoster (Shingles)
- Plan mergers and acquisitions effectively by identifying key players of the most promising
pipeline
- Devise corrective measures for pipeline projects by understanding Herpes Zoster (Shingles)
pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline

www.aarkstore.com

Table of Contents
Introduction 6
Global Markets Direct Report Coverage 6
Herpes Zoster (Shingles) Overview 7
Therapeutics Development 8
Pipeline Products for Herpes Zoster (Shingles) - Overview 8
Pipeline Products for Herpes Zoster (Shingles) - Comparative Analysis 9
Herpes Zoster (Shingles) - Therapeutics under Development by Companies 10
Herpes Zoster (Shingles) - Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Unknown Stage Products 15
Herpes Zoster (Shingles) - Products under Development by Companies 16
Herpes Zoster (Shingles) - Companies Involved in Therapeutics Development 17
GlaxoSmithKline plc 17

www.aarkstore.com

List Of Tables
Number of Products under Development for Herpes Zoster (Shingles), H2 2014 8
Number of Products under Development for Herpes Zoster (Shingles) - Comparative
Analysis, H2 2014 9
Number of Products under Development by Companies, H2 2014 11
Comparative Analysis by Late Stage Development, H2 2014 12
Comparative Analysis by Clinical Stage Development, H2 2014 13
Comparative Analysis by Early Stage Development, H2 2014 14
Comparative Analysis by Unknown Stage Development, H2 2014 15
Products under Development by Companies, H2 2014 16
Herpes Zoster (Shingles) - Pipeline by GlaxoSmithKline plc, H2 2014 17
Herpes Zoster (Shingles) - Pipeline by Merck & Co., Inc., H2 2014 18

www.aarkstore.com

List Of Figures
Number of Products under Development for Herpes Zoster (Shingles), H2 2014 8
Number of Products under Development for Herpes Zoster (Shingles) - Comparative Analysis,
H2 2014 9
Number of Products under Development by Companies, H2 2014 10
Comparative Analysis by Clinical Stage Development, H2 2014 13
Assessment by Monotherapy Products, H2 2014 24
Number of Products by Top 10 Target, H2 2014 25
Number of Products by Stage and Top 10 Target, H2 2014 26
Number of Products by Top 10 Mechanism of Action, H2 2014 27
Number of Products by Stage and Top 10 Mechanism of Action, H2 2014 28
Number of Products by Top 10 Route of Administration, H2 2014 29

www.aarkstore.com

Related Market Research reports:


Corticosteroid-Responsive Dermatoses - Pipeline Review, H1 2014



Hematological Tumor - Pipeline Review, H1 2014



Inflammation - Pipeline Review, H1 2014



Opioid Induced Side Effects - Pipeline Review, H1 2014



Skin Infections - Pipeline Review, H1 2014

www.aarkstore.com

Related Market Research reports:


Restenosis - Pipeline Review, H1 2014



Tauopathies - Pipeline Review, H1 2014



Nasopharyngitis (Common Cold) - Pipeline Review, H1 2014



Mucopolysaccharidosis III (MPS III) (Sanfilippo Syndrome) - Pipeline Review,
H1 2014



Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2014

www.aarkstore.com


Related documents


aarkstore herpes zoster shingles pipeline review
aarkstore essential thrombocythemia pipeline review
aarkstore fibrinogen deficiency factor i deficiency
aarkstore male infertility pipeline review h1 2015
aarkstore epilepsy pipeline review h2 2014
aarkstore hepatitis a pipeline review h1 2014


Related keywords